New England Journal of Medicine

Papers
(The median citation count of New England Journal of Medicine is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Clinical Characteristics of Coronavirus Disease 2019 in China19581
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine10906
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia10583
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine7434
Dexamethasone in Hospitalized Patients with Covid-196543
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-16457
Remdesivir for the Treatment of Covid-19 — Final Report5189
First Case of 2019 Novel Coronavirus in the United States4227
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-194120
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients3746
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma3567
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-193531
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany2940
Mental Health and the Covid-19 Pandemic2902
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure2644
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report2530
Dapagliflozin in Patients with Chronic Kidney Disease2402
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant2214
Fair Allocation of Scarce Medical Resources in the Time of Covid-192066
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting2065
Virtually Perfect? Telemedicine for Covid-192052
Empagliflozin in Heart Failure with a Preserved Ejection Fraction2022
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates1997
Neurologic Features in Severe SARS-CoV-2 Infection1924
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-191868
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series1852
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents1843
Cytokine Storm1833
Compassionate Use of Remdesivir for Patients with Severe Covid-191822
SARS-CoV-2 Infection in Children1748
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility1704
Clinical Characteristics of Covid-19 in New York City1664
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination1662
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results1658
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-191638
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young1581
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant1578
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-191560
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer1445
Multiorgan and Renal Tropism of SARS-CoV-21424
Critical Supply Shortages — The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic1409
Initial Invasive or Conservative Strategy for Stable Coronary Disease1402
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-191393
Genomewide Association Study of Severe Covid-19 with Respiratory Failure1348
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months1343
Hospitalization and Mortality among Black Patients and White Patients with Covid-191333
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia1326
Once-Weekly Semaglutide in Adults with Overweight or Obesity1295
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-191289
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-191250
Covid-19 — Navigating the Uncharted1236
Olaparib for Metastatic Castration-Resistant Prostate Cancer1236
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-191229
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-191204
New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race1176
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients1173
Monkeypox Virus Infection in Humans across 16 Countries — April–June 20221154
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults1125
Developing Covid-19 Vaccines at Pandemic Speed1104
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers1087
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination1083
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes1081
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma1079
Severe Covid-191064
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-191033
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure1031
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma1024
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host1020
Efficacy of Tocilizumab in Patients Hospitalized with Covid-191018
Remdesivir for 5 or 10 Days in Patients with Severe Covid-191017
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months1012
Lecanemab in Early Alzheimer’s Disease1011
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation1011
Multisystem Inflammatory Syndrome in Children in New York State1008
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington1001
Mild or Moderate Covid-19994
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant990
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer989
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19962
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors958
Spread of SARS-CoV-2 in the Icelandic Population958
Guillain–Barré Syndrome Associated with SARS-CoV-2951
Osimertinib in ResectedEGFR-Mutated Non–Small-Cell Lung Cancer950
Colchicine in Patients with Chronic Coronary Disease946
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia945
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine926
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma911
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms906
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma902
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine901
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC891
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes887
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates884
Defining the Epidemiology of Covid-19 — Studies Needed880
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia876
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19875
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel860
Endometriosis859
Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19851
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19846
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19845
The Effect of Advances in Lung-Cancer Treatment on Population Mortality835
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19830
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer811
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction804
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants801
Sotorasib for Lung Cancers with KRAS p.G12C Mutation793
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer791
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis790
How Structural Racism Works — Racist Policies as a Root Cause of U.S. Racial Health Inequities790
Waning Immunity after the BNT162b2 Vaccine in Israel786
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer774
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab772
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy771
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis770
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2769
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19766
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery764
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma761
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients758
Humoral Immune Response to SARS-CoV-2 in Iceland754
Tirzepatide Once Weekly for the Treatment of Obesity752
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination741
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers737
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction728
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol725
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19724
Responding to Covid-19 — A Once-in-a-Century Pandemic?719
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer719
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine708
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma708
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients704
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting702
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia686
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents685
HPV Vaccination and the Risk of Invasive Cervical Cancer677
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults676
Covid-19 and Health Care’s Digital Revolution670
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19654
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia654
False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications651
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile651
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer643
Neuropathological Features of Covid-19639
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes633
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons630
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease626
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar625
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine622
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer620
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis612
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination612
Covid-19 and Kidney Transplantation609
Rethinking Covid-19 Test Sensitivity — A Strategy for Containment603
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19603
Donanemab in Early Alzheimer’s Disease602
Trial of Psilocybin versus Escitalopram for Depression602
Vaccine Breakthrough Infections with SARS-CoV-2 Variants601
Facing Covid-19 in Italy — Ethics, Logistics, and Therapeutics on the Epidemic’s Front Line601
Autophagy in Human Diseases591
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19576
Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Final Report572
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes569
ST-Segment Elevation in Patients with Covid-19 — A Case Series568
New-Onset Diabetes in Covid-19561
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer555
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer554
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma547
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications545
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease544
Racial Health Disparities and Covid-19 — Caution and Context543
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer541
Rivaroxaban in Peripheral Artery Disease after Revascularization539
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa528
The Untold Toll — The Pandemic’s Effects on Patients without Covid-19526
Empagliflozin in Patients with Chronic Kidney Disease524
Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke520
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis513
The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction512
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19508
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant505
Pathophysiology of Inflammatory Bowel Diseases502
Capmatinib inMETExon 14–Mutated orMET-Amplified Non–Small-Cell Lung Cancer498
Racial Bias in Pulse Oximetry Measurement498
Neutralizing Activity of BNT162b2-Elicited Serum495
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest495
Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy493
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing491
Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women488
Children with Covid-19 in Pediatric Emergency Departments in Italy487
The Toughest Triage — Allocating Ventilators in a Pandemic486
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis483
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines480
Detection of Covid-19 in Children in Early January 2020 in Wuhan, China477
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis476
Covid-19 — Implications for the Health Care System464
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes464
Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer463
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations462
Acquired Resistance to KRASG12C Inhibition in Cancer452
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer450
Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China450
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma446
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia445
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients443
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine440
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization440
Avacopan for the Treatment of ANCA-Associated Vasculitis437
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection435
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19434
Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19434
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine425
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer423
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers422
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma421
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel419
Transmission of SARS-CoV-2 in Domestic Cats415
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease414
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer410
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19409
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer409
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5407
Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China405
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis405
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma403
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine403
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age398
Homologous and Heterologous Covid-19 Booster Vaccinations395
Evidence of Artemisinin-Resistant Malaria in Africa393
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation393
Evinacumab for Homozygous Familial Hypercholesterolemia393
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease389
Structural Racism, Social Risk Factors, and Covid-19 — A Dangerous Convergence for Black Americans387
Microvascular Injury in the Brains of Patients with Covid-19385
A Population-Based Study of Genes Previously Implicated in Breast Cancer383
Barrier Enclosure during Endotracheal Intubation383
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19383
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase382
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma381
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma378
SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia373
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines370
Diffuse Large B-Cell Lymphoma370
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons363
A Bivalent Omicron-Containing Booster Vaccine against Covid-19361
Migraine361
Spectrum of Fibrotic Lung Diseases360
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure359
Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer358
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma357
0.040060997009277